LongBio`s LP-003 achieves its fourth IND approval
25 Nov 2024 //
PR NEWSWIRE
LongBio Completes Series B2 Financing Led by Qiming Venture Partners
24 Sep 2024 //
PR NEWSWIRE
LongBio Unveils LP-005 Bi-Functional Complement Antibody At WCN2024
15 Apr 2024 //
PR NEWSWIRE
Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD
12 Mar 2024 //
PR NEWSWIRE